If you’ve been through the cycle of trying one psychiatric medication after another — each one either not working, causing side effects you couldn’t live with, or both — pharmacogenetic testing comes up a lot. GeneSight is the best-known brand. It is a real tool with a real use, and it is also widely oversold, so it’s worth being precise about what it does.
What is pharmacogenetic testing?
Pharmacogenetics is the study of how your genes influence the way your body processes medications. The key players are enzymes produced by genes in the cytochrome P450 system — particularly CYP2D6 and CYP2C19 — which metabolize a wide range of psychiatric medications. Depending on your genetic variants, you might be a “poor metabolizer” (the drug builds up and side effects intensify), an “ultrarapid metabolizer” (the drug clears before it can work), or somewhere in between.
A cheek swab is all it takes to find out where you fall, and that can be useful information when starting or adjusting psychiatric medications.
What the report actually says
GeneSight is one of the most widely used pharmacogenomic tests in psychiatry. It sorts medications into three categories, and it’s worth reading those categories carefully — they are about how you process a drug, not about whether it will help you:
✅ Use as Directed
No gene-drug interaction identified. Standard dosing applies.
⚠️ Moderate Interaction
Your metabolism may call for a dose adjustment or closer monitoring.
🔴 Significant Interaction
A larger effect on drug levels — more risk of side effects, or of the medication clearing before it can work.
The panel covers antidepressants (SSRIs, SNRIs, TCAs), antipsychotics, mood stabilizers, anti-anxiety medications, and non-stimulant ADHD medications — the range we prescribe at Affordable Psych.
Note: Affordable Psych does not prescribe stimulant medications (such as Adderall or Ritalin) or other controlled substances. Testing at our practice is used for non-stimulant ADHD treatments, antidepressants, mood stabilizers, and anti-anxiety medications.
What it does not tell you
It does not predict which antidepressant will make you feel better. Metabolism is about drug levels — how much of a medication ends up in your system and for how long. It says nothing about whether that particular medication suits your particular depression or anxiety. Two people who process a drug identically can respond to it completely differently.
This distinction matters because the marketing often blurs it. The FDA has specifically cautioned that claims these tests predict how a person will respond to a given medication are not supported by the evidence.
Where it genuinely helps
Explaining side effects you’ve already had
If a standard dose hit you unusually hard, poor metabolizer status is a concrete explanation rather than a shrug. That turns a bad experience into information you can use for the next decision.
Getting the dose right
Metabolizer status is most actionable as a dosing question. It can justify starting lower and going slower, or it can explain why an ordinary dose never seemed to do anything.
Narrowing a crowded field
When several reasonable options remain and nothing else separates them, knowing which ones you handle poorly is a fair tiebreaker. That is narrowing the field, not picking the winner.
On the evidence: results are mixed rather than settled. The largest randomized trial of pharmacogenetic-guided antidepressant treatment did not meet its primary endpoint — symptom improvement at eight weeks was not significantly different from treatment as usual — though some secondary measures favored the guided group. Much of the supporting research has been funded by test manufacturers. Treat any source promising dramatically faster results with skepticism.
How the test works
The process is straightforward. You’ll receive a cheek swab kit, either after your telehealth appointment or by mail. You collect the sample at home and return it. Results come back within about 5–7 business days and we review them together at a follow-up, alongside your history, your current symptoms, and what you’ve already tried.
Genetics are one input among several, and not the strongest one. How you actually felt on past medications remains better evidence than any report.
What it costs
Because Affordable Psych operates on a cash-pay model, we don’t bill insurance for this or anything else. Some plans do cover pharmacogenetic testing when there is documented clinical justification, and that is worth checking with your own insurer directly. Either way, we’ll tell you what to expect on cost before anything is ordered.
When it’s worth considering
- You’ve had side effects at doses most people tolerate without trouble
- Several medications in the same class have done nothing at all
- A past reaction was severe enough that nobody wants to guess again
- You’re taking multiple medications and there’s a question about interactions
The case is weakest as a first step. If you have never tried a psychiatric medication, a result rarely changes what a sensible starting choice would have been anyway.
The bottom line
Pharmacogenetic testing answers a narrow question well: how your body handles certain drugs. It does not answer the bigger one about which medication will help. Used for what it actually measures — usually to explain something that already happened rather than to predict something that hasn’t — it earns its place. Sold as a shortcut past trial and error, it sets people up for disappointment. If you think there’s a question it could answer for you, bring it up and we’ll talk it through. Telehealth makes it easy to order the test and review the results.